Exagen Inc. (NASDAQ:XGN) Q2 2025 Earnings Call Transcript

Exagen Inc. (NASDAQ:XGN) Q2 2025 Earnings Call Transcript July 29, 2025

Exagen Inc. reports earnings inline with expectations. Reported EPS is $-0.18 EPS, expectations were $-0.18.

Operator: Greetings, and welcome to the Exagen Inc. Q2 2025 Earnings Call. [Operator Instructions]. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ryan Douglas, Investor Relations. Thank you. You may begin.

Ryan Douglas: Good morning, and thank you for joining us....